All posts tagged
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
The UK Steps Up its Game in Automated CRISPR Gene Editing
Europe’s Lag in the Gene Editing Race may leave its Biotech Obsolete
These are our 10 Most Read Biotech Articles of 2016
Our Startup Battle Winner uses CRISPR in a Whole New Way
UPDATE: No Clear Winner in the CRISPR Patent Battle
Evotec gets hold of CRISPR in a new Partnership with Merck
CRISPR meets RNAi: a whole new Targeted Therapy
How much of a Gamble is Investing in CRISPR?
The CRISPR Revolution is here, but how can we make it Useful?
Promising Boston-based CRISPR Startup hits up Horizon to fix Gene Misregulation
Labiotech UG, All Rights Reserved -
Send this to friend